Rakuten Investment Management Inc. Makes New Investment in Amrize Ltd $AMRZ

Rakuten Investment Management Inc. purchased a new stake in Amrize Ltd (NYSE:AMRZ) in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 32,365 shares of the company’s stock, valued at approximately $1,220,000.

Several other institutional investors have also recently made changes to their positions in AMRZ. Amundi raised its holdings in shares of Amrize by 30.9% during the first quarter. Amundi now owns 1,654,739 shares of the company’s stock valued at $92,698,000 after purchasing an additional 390,750 shares during the period. DJE Kapital AG grew its stake in shares of Amrize by 45.9% in the 1st quarter. DJE Kapital AG now owns 1,113,036 shares of the company’s stock valued at $60,194,000 after buying an additional 350,149 shares during the period. Great Lakes Advisors LLC acquired a new stake in shares of Amrize in the 2nd quarter valued at about $16,975,000. Ancora Advisors LLC acquired a new stake in shares of Amrize in the 2nd quarter valued at about $15,112,000. Finally, Assetmark Inc. increased its position in Amrize by 18,567.2% in the 1st quarter. Assetmark Inc. now owns 250,887 shares of the company’s stock valued at $14,055,000 after buying an additional 249,543 shares in the last quarter.

Insider Transactions at Amrize

In related news, insider Jaime Hill bought 1,500 shares of the company’s stock in a transaction dated Tuesday, August 11th. The shares were bought at an average price of $47.12 per share, for a total transaction of $70,680.00. Following the completion of the acquisition, the insider directly owned 29,698 shares of the company’s stock, valued at $1,399,369.76. This trade represents a 5.32% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Jan Jenisch purchased 4,000 shares of the stock in a transaction that occurred on Wednesday, September 2nd. The stock was bought at an average cost of $42.50 per share, with a total value of $170,000.00. Following the completion of the transaction, the chief executive officer directly owned 519,000 shares in the company, valued at $22,057,500. The trade was a 0.78% increase in their position. The SEC filing for this purchase provides additional information. Over the last quarter, insiders bought 48,983 shares of company stock valued at $2,158,755. Corporate insiders own 0.54% of the company’s stock.

Amrize Stock Down 1.8%

Amrize stock opened at $41.90 on Friday. The firm has a market capitalization of $23.17 billion, a price-to-earnings ratio of 18.96, a price-to-earnings-growth ratio of 1.64 and a beta of 0.04. The firm’s fifty day moving average price is $39.53 and its two-hundred day moving average price is $50.30. Amrize Ltd has a 1-year low of $35.78 and a 1-year high of $65.94. The company has a current ratio of 1.07, a quick ratio of 0.67 and a debt-to-equity ratio of 0.33.

Amrize (NYSE:AMRZ) last posted its earnings results on Wednesday, October 28th. The company reported $1.05 EPS for the quarter, hitting the consensus estimate of $1.05. The company had revenue of $3.77 billion during the quarter. Amrize had a net margin of 9.93% and a return on equity of 10.02%. During the same period in the previous year, the firm earned $0.98 earnings per share. The company’s revenue was up 2.6% on a year-over-year basis. On average, equities research analysts predict that Amrize Ltd will post 2.30 earnings per share for the current fiscal year.

Amrize Announces Dividend

The business also recently disclosed a dividend, which will be paid on Wednesday, November 18th. Shareholders of record on Tuesday, November 10th will be issued a dividend of $0.11 per share. The ex-dividend date of this dividend is Tuesday, November 10th. Amrize’s payout ratio is currently 4.98%.

Analyst Ratings Changes

A number of brokerages recently commented on AMRZ. Longbow Research began coverage on Amrize in a research report on Monday, October 12th. They issued a “buy” rating for the company. JPMorgan Chase & Co. cut their price target on Amrize from $52.00 to $48.00 and set a “neutral” rating on the stock in a report on Tuesday, October 13th. Weiss Ratings cut Amrize from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Thursday, October 8th. Zacks Research downgraded Amrize from a “hold” rating to a “strong sell” rating in a report on Wednesday, August 19th. Finally, Wall Street Zen lowered Amrize from a “hold” rating to a “sell” rating in a research report on Saturday. Eight research analysts have rated the stock with a Buy rating, six have given a Hold rating and four have assigned a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $49.06.

About Amrize

Amrize is a North American building materials and construction solutions company serving customers across the United States and Canada. Its operations span the construction materials and building envelope markets.

The company supplies cement, aggregates, ready-mix concrete and asphalt, as well as roofing and other building-envelope products and services. These materials and solutions support residential, commercial and infrastructure projects.

Amrize became an independent publicly traded company in 2025 through the spin-off of Holcim’s North American business.